A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Clinical trial NCT06335134 · COMPLETED
Trial details
- NCT number
- NCT06335134
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2024-01-08
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.